Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center

In 2005, Japan?s big drug firm Takeda acquired a company in North America for the first time. That company was Syrrx, a private San Diego-based biotech that used X-ray crystallography to help determine the structures of disease-related molecules so drugs could be designed to target them. Now, 14 years and multiple other acquisitions of North [?]